Phosphate
Brand names: Phosphate Sandoz, Phosphate-binders see separate entries
Phosphate supplements are used to correct or prevent hypophosphataemia, which may arise in refeeding syndrome, renal phosphate wasting, or other depletion states.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
Supplemental phosphate replenishes the body's phosphate pool, supporting cellular energy metabolism, bone mineralisation and acid-base buffering.
Prescribing in practice
- Avoid or use with great caution in significant renal impairment and hyperphosphataemia, as accumulation can cause dangerous hyperphosphataemia and metabolic disturbance.
- Intravenous phosphate must be infused slowly with cardiac and biochemical monitoring because rapid administration risks hypocalcaemia, arrhythmia and hypotension.
- Co-administered potassium and sodium content of phosphate preparations should be accounted for, particularly in renal or cardiac patients.
Monitoring
Monitor serum phosphate, calcium, potassium and renal function during replacement, especially with parenteral therapy.
Counselling the patient
- Oral phosphate can cause diarrhoea or stomach upset; take as directed.
- Attend for the blood tests your team arranges to check your phosphate and calcium levels.
Evidence & guidelines
Phosphate replacement is standard practice in correcting hypophosphataemia, with parenteral use guided by established critical-care and electrolyte-management protocols.
Reference: NICE NG32; UK guidelines; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- Weight-Based Levothyroxine Dose Calculator · Thyroid
- Cryoprecipitate Dose Calculator for Fibrinogen Replacement · Transfusion Medicine
- Free Water Deficit in Hypernatraemia · Fluid / Electrolytes
- Calcium-Phosphate Product · Electrolytes
- Potassium Deficit Calculator · Electrolytes
- Indications for Renal Replacement Therapy (RRT) in AKI · Treatment Decision
- Diabetic Ketoacidosis (DKA) · JBDS 2013 / Joint British Diabetes Societies; NICE NG17
- Adult Hypoglycaemia (Treated Diabetes) · JBDS-IP (2023): Hospital Management of Hypoglycaemia
- Adrenal Crisis · Society for Endocrinology Emergency Guidance (2024)
- Type 2 Diabetes Management · NICE NG28 2022
- Hyperthyroidism Management · BTA / ETA 2018
- Adrenal Insufficiency · Society of Endocrinology / ESE 2016